BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32544978)

  • 1. Screening for New Markers to Assess Thyroid Hormone Action by OMICs Analysis of Human Samples.
    Friedrich N; Pietzner M; Engelmann B; Homuth G; Führer D; Brabant G; Wallaschofski H; Völker U
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):479-487. PubMed ID: 32544978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers.
    Nock S; Höfig C; Harder L; Schomburg L; Brabant G; Mittag J
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):473-478. PubMed ID: 31590191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5L Constitutes a Novel Biomarker for Integrated Hepatic Thyroid Hormone Action.
    Nock S; Johann K; Harder L; Wirth EK; Renko K; Hoefig CS; Kracke V; Hackler J; Engelmann B; Rauner M; Köhrle J; Schomburg L; Homuth G; Völker U; Brabant G; Mittag J
    Thyroid; 2020 Jun; 30(6):908-923. PubMed ID: 32183611
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empowering thyroid hormone research in human subjects using OMICs technologies.
    Pietzner M; Kacprowski T; Friedrich N
    J Endocrinol; 2018 Jul; 238(1):R13-R29. PubMed ID: 29724864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unstable Thyroid Function in Older Adults Is Caused by Alterations in Both Thyroid and Pituitary Physiology and Is Associated with Increased Mortality.
    Mammen JS; McGready J; Ladenson PW; Simonsick EM
    Thyroid; 2017 Nov; 27(11):1370-1377. PubMed ID: 28854871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid in pregnancy: From physiology to screening.
    Springer D; Jiskra J; Limanova Z; Zima T; Potlukova E
    Crit Rev Clin Lab Sci; 2017 Mar; 54(2):102-116. PubMed ID: 28102101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subclinical thyroid disease--should we treat, should we screen for it?].
    Trbojević B
    Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing thyroid disease in general practice.
    Walsh JP
    Med J Aust; 2016 Aug; 205(4):179-84. PubMed ID: 27510349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid function tests].
    Uchimura H
    Rinsho Byori; 2001 Apr; 49(4):319-24. PubMed ID: 11391943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic thyroid stimulating hormone tests: do they still have a role?
    Allahabadia A; Weetman AP
    J Endocrinol Invest; 2003; 26(7 Suppl):31-8. PubMed ID: 14604064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: thyroid function in psychiatric illness.
    Hein MD; Jackson IM
    Gen Hosp Psychiatry; 1990 Jul; 12(4):232-44. PubMed ID: 2198197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review.
    Razvi S; Hostalek U
    Curr Med Res Opin; 2019 Jul; 35(7):1215-1220. PubMed ID: 30648440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of refetoff syndrome: selective venous sampling for TSH is useful in differentiating thyroid hormone resistance from TSH secreting tumor.
    Itagaki Y; Yoshida K; Sakurada T; Kiso Y; Arai T; Kaise N; Kaise K; Hanew K; Yamamoto M; Saito S
    Tohoku J Exp Med; 1989 Jan; 157(1):69-78. PubMed ID: 2711378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of the fetal urinary metabolome and peptidome for the prediction of postnatal renal outcome in fetuses with PUV.
    Buffin-Meyer B; Klein J; Breuil B; Muller F; Moulos P; Groussolles M; Bouali O; Bascands JL; Decramer S; Schanstra JP
    J Proteomics; 2018 Jul; 184():1-9. PubMed ID: 29929039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
    Surks MI; Ortiz E; Daniels GH; Sawin CT; Col NF; Cobin RH; Franklyn JA; Hershman JM; Burman KD; Denke MA; Gorman C; Cooper RS; Weissman NJ
    JAMA; 2004 Jan; 291(2):228-38. PubMed ID: 14722150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable biological activity of thyroid-stimulating hormone.
    Beck-Peccoz P; Persani L
    Eur J Endocrinol; 1994 Oct; 131(4):331-40. PubMed ID: 7921220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese.
    Okamura K; Ueda K; Sone H; Ikenoue H; Hasuo Y; Sato K; Yoshinari M; Fujishima M
    J Am Geriatr Soc; 1989 Apr; 37(4):317-22. PubMed ID: 2493494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of highly sensitive thyroid stimulating hormone immunoradiometric assay (RIABEAD II) kit].
    Kamoi K; Kaneko K; Matsunaga K; Yamazaki M; Murayama S; Sato T
    Radioisotopes; 1988 Feb; 37(2):95-8. PubMed ID: 3393703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.